000 | 01675 a2200469 4500 | ||
---|---|---|---|
005 | 20250517010448.0 | ||
264 | 0 | _c20150629 | |
008 | 201506s 0 0 eng d | ||
022 | _a1365-2249 | ||
024 | 7 |
_a10.1111/cei.12573 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeikal, N M | |
245 | 0 | 0 |
_aLaboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cMay 2015 |
||
300 |
_a218-26 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Anticardiolipin _xblood |
650 | 0 | 4 |
_aAntiphospholipid Syndrome _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 |
_aLupus Coagulation Inhibitor _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPhosphatidylserines _ximmunology |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProthrombin _ximmunology |
650 | 0 | 4 |
_abeta 2-Glycoprotein I _ximmunology |
700 | 1 | _aJaskowski, T D | |
700 | 1 | _aMalmberg, E | |
700 | 1 | _aLakos, G | |
700 | 1 | _aBranch, D W | |
700 | 1 | _aTebo, A E | |
773 | 0 |
_tClinical and experimental immunology _gvol. 180 _gno. 2 _gp. 218-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12573 _zAvailable from publisher's website |
999 |
_c24471551 _d24471551 |